Vaccination

Meningitis vaccine tackles epidemic which plagued Africa for a century

By: Information Daily Staff Writer
Published: Thursday, September 12, 2013 - 03:30 GMT Jump to Comments

The vaccine, called MenAfriVac, is able to protect Africa’s 21-country ‘meningitis belt’ from epidemic A meningococcal disease.

The new study, undertaken by the African Meningococcal Carriage Consortium and published in The Lancet, measured the effect of MenAfriVac on the spread of meningitis when compared to unvaccinated regions during an epidemic.

The researchers discovered that, by giving all 1-29 year olds in three regions of Chad a shot of the vaccine, it significantly reduced incidence of all cases of meningitis by 94 per cent, and carriage prevalence of the epidemic strain dwindled by 98 per cent.

In unvaccinated parts of Chad, however, the epidemic persisted.

Lead author Professor Brian Greenwood from the London School of Hygiene & Tropical Medicine explained the importance of the study; “Before this study, mass vaccination campaigns in countries such as Burkina Faso had shown MenAfriVac to be safe and highly effective, resulting in the lowest number of confirmed meningitis A cases in over a decade”, he said.

“But in Burkina Faso the vaccine was introduced at a time of falling incidence rates and decreasing transmission, potentially enhancing its true effect and making it difficult to study the vaccine’s impact.”

Deadly epidemics of meningitis A are frequent in Africa’s so-called ‘meningitis belt’, a band of 21 sub-Saharan countries which extends from Senegal to Ethiopia. It is estimated that around 450 million people are at risk.

Greenwood added, “While our findings support the continuing roll-out of this vaccine across the African meningitis belt, continuing surveillance and further carriage studies in countries of the African meningitis belt will be needed to confirm the duration of protection provided by this vaccine.”

Comments

Latest

The Citizens Advice Bureau recently published a report entitled 'Personal data empowerment: time for a fairer…

Tapping into the potential of mobile technology can release healthcare staff from offices and give them the tools…

The whole purpose of clinical trials is to gauge the efficacy and safety of particular treatments. But what about…

We all know how frustrating it is to find that elusive parking space. But it’s not until we quantify our…

Devolution may help rebalance the UK’s growth, but its strategy and execution need to be carefully thought…

In a recent blog post, Dan Slee, director of the communications and PR website Comms2Point0, suggested that open…

Back in 2013, I wrote a piece for The Information Daily about how that year would be the year of digital by default,…

When GP Chair of NHS Cannock Chase CCG, Dr Jonny McMahon, agreed to take part in Reality Bites - The National…

Bath & NE Somerset council has developed an approach to opening up its data that is delivering rapid returns for…

In Simon Stevens’ brave new world will we have our own GPs? Will we still have to wait for weeks to get…

John Tacchi is a qualified lawyer and former investment banker who recently “graduated” from the NHS…

It seems that David Cameron’s commitment to ensure 95% of the country will have access to superfast broadband…